Treatment of knee osteoarthritis with Lyprinol®, lipid extract of the green-lipped mussel - A double-blind placebo-controlled study

Progress in Nutrition

Volumn 6, Issue 1, 2004, Pages 17-31

  Lau, C S ^a   Chiu, P K Y ^a   Chu, E M Y ^a   Cheng, I Y W ^a   Tang, W M ^a   Man, R Y K ^a   Halpern, G M ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Chronic osteoarthritis; Essential fatty acids; Lyprinol ; Natural remedies; Perna canaliculus; Quality of life

Indexed keywords

ANALGESIC AGENT; C REACTIVE PROTEIN; LIPID; LYPRINOL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; PARACETAMOL; PLACEBO;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INCIDENCE; KNEE OSTEOARTHRITIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MUSSEL; NAUSEA; NOCICEPTION; PAIN; PAIN ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOMATOLOGY; TRADITIONAL MEDICINE; VISUAL ANALOG SCALE;

ANIMALIA; PERNA; PERNA CANALICULUS;

EID: 4344649981     PISSN: 11298723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Murray JL, Lopez AD. The global burden of disease in 1990: final results and their sensitivity to alternative epidemiological perspectives, discount rates, age-weights and disability weights. In: Murray JL, Lopez AD, editors. The global burden of disease. Geneva: World Health Organization; 1996: 262-3.
2. Centers for Disease Control and Prevention. Arthritis prevalence and activity limitations - United States, 1990. MWR Morb Mortal Wkly Rep 1994; 43: 433-8.
3. Woo J, Ho SC, Lau J, Leung PC. Musculoskeletal complaints and associated consequences in elderly Chinese aged 70 years and over. J Rheumatol 1994; 21: 1927-31.
4. American College of Rheumatology. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 2000; 43: 1905-15.
5. Lichenstein D, Syngal S, Wolfe MM. Non-steroidal anti-inflammatory drugs and the gastrointestinal tract: the double-edged sword. Arthritis Rheum 1995; 38: 5-18.
6. Paulus HE. FDA arthritis advisory committee meeting: serious gastrointestinal toxicity of non-steroidal anti-inflammatory drugs, etc. Arthritis Rheum 1988; 31: 1450-1.
7. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non-steroidal anti-inflammatory drugs: a randomized, double-blind, placebo controlled trial. Ann Intern Med 1995; 123: 241-9.
8. Singh G, Ramey DR, Morfeld D, et al. Gastrointestinal tract complications of non-steroidal anti-inflammatory drug treatment in rheumatoid arthritis: a prospective observational cohort study. Arch Intern Med 1996; 156: 1530-6.
9. Ramsey SD, Spencer AC, Topolski TD, Belz B, Patrick DL. Use of alternative therapies by older adults with osteoarthritis. Arthritis Care Res 2001; 45: 222-7.
10. Rainsford KD, Whitehouse MW. Gastroprotective and anti-inflammatory properties of green-lipped mussel (Perna canaliculus) preparation. Arzn Forsch 1980; 30: 2128-32.
11. Whitehouse MW, Macrides TA, et al. Anti-inflammatory activity of a lipid fraction (Lyprinol®) from the NZ green-lipped mussel. Inflammopharmacol 1997; 5: 237-46.
12. Gibson RG, Gibson S, Conway V, Chappel D. Perna canaliculus in the treatment of arthritis. Practitioner 1980; 224: 955-60.
13. Altman R, Asch E, Bloch D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 1039-49.
14. Chiu KY, Ko PS, Lam P. Correlation of scores derived from surgeons and patients to assess total knee replacements. HK J Orthop Surg 2001; 5: 32-9.
15. Chu EMY. Translation of the Arthritis Impact Measurement Scales-2 into Chinese: validation and utilization, and the development of a short form Chinese Arthritis Impact Measurement Scales-2 questionnaire. PhD Thesis. The University of Hong Kong 2003.
16. Chu EMY, Chiu KY, Wong RWS, Tang WM, Lau CS. The translation and validation of arthritis impact measurement scales 2 (AIMS2) into Chinese - CAIMS2. Arthritis Care Res (in press).
17. Macrides TA, Treschow AP. The anti-inflammatory effects of omega-3 tetraenoic fatty acids isolated from a lipid extract (Lyprinol®) from the New Zealand green-lipped mussel. Abstract, 88th American Oil Chemists Society
18. Dugas B. Lyprinol® inhibits LTB4 production by human monocytes. Allerg Immunol 2000; 32 (9): 284-9.
19. Sinclair AJ, Murphy KJ, Li D. Marine lipids: overview "news insights and lipid composition of Lyprinol®". Allerg Immunol 2000; 32 (9): 261-71.
20. Lau CS, Morley KD, Belch JJF. Effects of Maxepa fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis - a double blind placebo controlled study. Brit J Rheumatol 1993; 52: 443-8.
21. Halpern GM. Anti-inflammatory effects of a stabilized lipid extract of Perna canaliculus (Lyprinol®). Allerg Immunol 2000; 32 (9 : 272-8.
22. Harbison SJ, Whitehouse MW. Possible steroid-sparing effect in asthma of Lyprinol®, a shellfish lipid extract. Med J Aust 2000; 173 (10): 560.
23. Shiels IA, Whitehouse MW. Lyprinol®: anti-inflammatory and uterine-relaxant activities in rats, with special reference to a model for dysmenorrhea. Allerg Immunol 2000; 32 (9): 279-83.
24. Gibson SLM, Gibson RG. The treatment of arthritis with a lipid extract of Perna canaliculus: a randomized trial. Compl Ther Med 1998; 6: 122-6.
25. Hoaglund ET, Yau AC, Wong WL. Osteoarthritis of the hip and other joints in southern Chinese in Hong Kong. J Am Bone Joint Surg 1973; 55: 545-57.
26. Hoaglund FR, Oishi C, Gialamas GG. Extreme variation in racial rates of total hip arthroplasty for primary coxarthrosis: a population-based study in San Francisco. Ann Rheum Discovery 1995; 54: 107-10.
27. Lau EC, Cooper C, Lam D, Chan VN, Tsang KK, Sham A. Factors associated with osteoarthritis of the hip and knee in Hong Kong Chinese: obesity, joint injury, and occupational activities. Am J Epidemiol 2000; 152: 855-62.
28. Angell M and Kassirer IP. Alternative medicine - the risks of untested and unregulated remedies. New Engl J Med 1998; 339: 839-41.
29. Belch JJF, Ansell D, Madhok R, O'Dowd A, Sturrock RD. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double-blind placebo controlled study. Ann Rheum Dis 1988; 47: 96-104.
30. Atherton DI. Towards the safer use of traditional remedies. Greater awareness of toxicity is needed. Brit. Med. J. 1994; 308: 673-4.